Participants on the highest dose (15 mg) achieved an average weight reduction of 22.9% over three years, marking one of the longest documented sustained weight loss effects in obesity pharmacotherapy
5-Alpha Reductase Inhibitors (Finasteride, Dutasteride) and TRT - Essential context on how true DHT blockers work, their side effect profile, and how they interact with testosterone therapy
Notable examples include short-acting agents such as exenatide and lixisenatide, as well as long-acting formulations like semaglutide, dulaglutide, and liraglutide
Synthetic analogs of GLP-1 have also been studied in metabolic research for their prolonged activity and receptor interaction
Yang W-Y, Lee Y, Lu H, Chou C-H, Wang C
We recommend patients work with their Willow physician to slowly decrease their dose in order to maintain their weight loss achievements